Literature DB >> 1828961

The value of necropsy in oncology.

L Di Furia1, A Piga, S Marmili, R Breccia, C Rubini, C A Beltrami, G M Mariuzzi, R Cellerino.   

Abstract

The effectiveness of diagnostic procedures in cancer patients was evaluated by comparing clinical with necropsy findings. Necropsy and clinical records of 102 patients were reviewed for primary site and histology of tumour, metastatic sites, presence of second neoplasms, associated non-neoplastic diseases, terminal illness and cause of death. Major discordances between clinical and postmortem findings were found in 34 (33%) cases: in 10 of these a correct clinical definition of site and histology of the primary tumour would have resulted in a change of management and prognosis; in 4 cases in which a major non-neoplastic pathology had been responsible for death, correct diagnosis might have resulted in prolongation of survival. Spread of disease was generally underestimated, even for metastases in clinically accessible organs. Even more disappointing were the clinical data related to terminal illness and cause of death (43% overall concordance).

Entities:  

Mesh:

Year:  1991        PMID: 1828961     DOI: 10.1016/0277-5379(91)90216-z

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Factors predicting cases with unexpected clinical findings at necropsy.

Authors:  I A Robinson; N J Marley
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

2.  Vasculopathy and antiphospholipid antibodies in systemic lupus.

Authors:  J C Piette; C Frances; T Papo; M Karmochkine
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

3.  Relative friendly death certificates.

Authors:  E W Benbow
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

4.  The anti-cancer effects of quinolone antibiotics?

Authors:  M Paul; A Gafter-Gvili; A Fraser; L Leibovici
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

Review 5.  A systemic review of toxic death in clinical oncology trials: an Achilles' heel in safety reporting revisited.

Authors:  B Penninckx; W M Van de Voorde; A Casado; N Reed; C Moulin; M Karrasch
Journal:  Br J Cancer       Date:  2012-06-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.